Skip to main content
PolicySpeak
← All files
ITA

I-Tech AB

Company · Sweden · EU Transparency Register 887251998922-15

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #720 by legislative files engaged — a count of participation, not a measure of influence.

0.6
declared lobbying FTE
self-declared
€300K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2025
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Head office
Mölndal, Sweden

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track I-Tech in PolicySpeak: request access →

Work at I-Tech AB? so we know who speaks for it.

Follow the file I-Tech AB engages with

One email on Tuesdays when a new position is filed on this file, from I-Tech AB or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

I-Tech AB filed 1 position on 5 Mar 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Evaluation of the Biocidal Products Regulationfiled 5 Mar 2026PDFsource

Contribution to the Evaluation of the Biocidal Products Regulation (EU) No 528/2012 I-Tech AB (“I-Tech”) is a Swedish biotechnology company specialising in marine antifouling solutions. A long-time recipient of EU funding, I-Tech is the developer of Selektope® (medetomidine), an innovative biocidal active substance currently approved under the BPR.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from I-Tech AB’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.